Biotech Values

[DewDiligence]

FDA approves Opdivo/Yervoy combination 2.5 months before PDUFA date:

https://www.businesswire.com/news/home/20250408873356/en/U.S.-Food-and-Drug-Administration-Approves-Opdivo-nivolumab-plus-Yervoy-ipilimumab-as-a-Treatment-for-Patients-with-Previously-Untreated-Microsatellite-Instability-High-or-Mismatch-Repair-Deficient-Unresectable-or-Metastatic-Colorectal-Cancer1

The PDUFA date was 6/23/25.